mCRP may potentially benefit from Lyn... - Advanced Prostate...
mCRP may potentially benefit from Lynparza in combination with abiraterone regardless of mutation status
Written by
George71
To view profiles and participate in discussions please or .
Read more about...
1 Reply
•
Hmmm very interesting, it appears that they are clearly including the Ar-V7 mutation.
That's very non-intuitive to me. There is no doubt a complex story explaining this.
Not what you're looking for?
You may also like...
Diagnosed with Stage 4 Metastatic PCa in the end of May
Hi, I am new here. I was initially diagnosed 3 1/2 years ago by a urologist with a very small,...
Is There a Benefit of Addition Docetaxel, Abiraterone, Celecoxib, or Zoledronic Acid in Initial Treatments for Patients Older Than 70 Years?
New study below [1].
I can't recall when the United States Preventive Services Task Force [USPSTF]...
Article: ADT May Increase Risk of Death From Cardiovascular Disease in Prostate Cancer
Conclusion: ADT recipients had a significantly increased risk of death from stroke and ischemic...
Substantial remission of prostate adenocarcinoma with dendritic cell therapy APCEDEN® in combination with chemotherapy 29 Oct 2019
Has anyone else tried the APCEDEN vaccine? Can we get it here in the U.S.?
Substantial remission...
Those of you with BRCA2 germline mutation,Gleason 9-10, stage T3- T4 upon diagnosis,How long from start of ADT(Lupron) to hormone resistance
I have BRCA2 germline mutation, Initial diagnosis 2015: Gleason 9, T3bN1M0, Aggressive disease. PSA...
Hi: 
Least damaging ADT?
Does Medicare cover nuclear bone scan for advanced prostate cancer
False Hope?
Lu 177 overseas
